Nationwide Fund Advisors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Nationwide Fund Advisors’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-104,474	Closed	-$18.1M	–	3455
2015 Q1	$18.1M	Sell	104,474 -28,118	-21%	-$4.13M	0.07%	342
2014 Q4	$15.2M	Sell	132,592 -29,295	-18%	-$3.55M	0.07%	377
2014 Q3	$25.3M	Sell	161,887 -20,917	-11%	-$3.03M	0.11%	223
2014 Q2	$22.5M	Sell	182,804 -11,218	-6%	-$1.24M	0.09%	263
2014 Q1	$20.1M	Buy	194,022 +384	+0.2%	+$39.3K	0.09%	267
2013 Q4	$17.4M	Buy	193,638 +72,434	+60%	+$5.78M	0.07%	334
2013 Q3	$8.11M	Buy	121,204 +72,139	+147%	+$4.97M	0.04%	641
2013 Q2	$3.25M	Buy	+49,065	New	+$2.81M	0.02%	1042

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Nationwide Fund Advisors's SLXP Position: Q2 2015 in Review

Nationwide Fund Advisors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 104,474 shares — an estimated $18.1M sold.

Nationwide Fund Advisors first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $25.3M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Nationwide Fund Advisors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Nationwide Fund Advisors sold 104,474 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $18.1M.
Nationwide Fund Advisors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Nationwide Fund Advisors's SALIX PHARMACEUTICALS LTD DEL position peaked at $25.3M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Nationwide Fund Advisors's 13F filing for Q2 2015, filed 29 Jul 2015.